• Home

  • Documents

  • Clinical Application of HER2-Directed Therapies in Breast Cancer
18

Clinical Application of HER2-Directed Therapies in Breast Cancer

Tags:

Embed Size (px)

DESCRIPTION

Clinical Application of HER2-Directed Therapies in Breast Cancer. HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS – 2 y vs 1 y. ALTTO Trial: Schema. MARIANNE: Phase 3 Trial in HER2+ Breast Cancer (Locally Recurrent/Progressive Advanced or Metastatic). Abbreviations. - PowerPoint PPT Presentation

Citation preview

Page 1: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 2: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 3: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 4: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 5: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 6: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 7: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 8: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 9: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 10: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 11: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 12: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 13: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 14: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 15: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 16: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 17: Clinical Application of HER2-Directed Therapies in Breast Cancer
Page 18: Clinical Application of HER2-Directed Therapies in Breast Cancer

Host-directed therapies for infectious diseases: current ... · Vol 16 April 2016 e47 Review Host-directed therapies for infectious diseases: current status, recent progress, and

Host-directed therapies for infectious diseases: current ... · Vol 16 April 2016 e47 Review Host-directed therapies for infectious diseases: current status, recent progress, and

Documents
Recent treatment advances in HER2-positive metastatic ......Summary The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic

Recent treatment advances in HER2-positive metastatic ......Summary The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic

Documents
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease · 2017. 8. 29. · Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease Lidia Bakota1 • Roland Brandt1

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease · 2017. 8. 29. · Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease Lidia Bakota1 • Roland Brandt1

Documents
InTech-Alternative Therapies for Septic Shock Beyond Early Goal Directed Therapy

InTech-Alternative Therapies for Septic Shock Beyond Early Goal Directed Therapy

Documents
Recent advances in novel targeted therapies for HER2 ...karentysonspage.org/Murphy 2012 rec advances in... · Anti-Cancer Drugs 2012, 23:765–776 Keywords: antibody–drug conjugates,

Recent advances in novel targeted therapies for HER2 ...karentysonspage.org/Murphy 2012 rec advances in... · Anti-Cancer Drugs 2012, 23:765–776 Keywords: antibody–drug conjugates,

Documents
Synthetic lethality between HER2 and transaldolase in ......metastatic breast cancer fail to respond initially to the most advanced HER2 targeted therapies 11 , and almost all patients

Synthetic lethality between HER2 and transaldolase in ......metastatic breast cancer fail to respond initially to the most advanced HER2 targeted therapies 11 , and almost all patients

Documents
SBT6050, a HER2-Directed TLR8 Therapeutic, is a Systemically Administered, Tumor ... · 2020. 5. 28. · HER2-expressing or HER2 negative EMT6 tumor cells 60 days after initial tumor

SBT6050, a HER2-Directed TLR8 Therapeutic, is a Systemically Administered, Tumor ... · 2020. 5. 28. · HER2-expressing or HER2 negative EMT6 tumor cells 60 days after initial tumor

Documents
Sponsored By:. SABCS 2011 Review: HER2-Directed Therapy in Breast Cancer Chau Dang, MD Assistant Professor of Medicine Weill Cornell Medical College Breast

Sponsored By:. SABCS 2011 Review: HER2-Directed Therapy in Breast Cancer Chau Dang, MD Assistant Professor of Medicine Weill Cornell Medical College Breast

Documents
MCF10A Her2

MCF10A Her2

Documents
Funding of High Cost Biotechnology and Other Innovative ... · HER2 Human epidermal growth factor receptor 2 protein ... and macromolecule solutions are ‘targeted’ therapies i.e

Funding of High Cost Biotechnology and Other Innovative ... · HER2 Human epidermal growth factor receptor 2 protein ... and macromolecule solutions are ‘targeted’ therapies i.e

Documents
Activating HER2 Mutations in HER2 Gene ... - Cancer Discovery · 224 | CANCER DISCOVERYFEBRUARY 2013 Activating HER2 Mutations in HER2 Gene Amplifi cation Negative Breast Cancer

Activating HER2 Mutations in HER2 Gene ... - Cancer Discovery · 224 | CANCER DISCOVERYFEBRUARY 2013 Activating HER2 Mutations in HER2 Gene Amplifi cation Negative Breast Cancer

Documents
Chapter 13 Overview Insight therapies Insight therapies Relationship therapies Relationship therapies Behavior therapies Behavior therapies Cognitive therapies

Chapter 13 Overview Insight therapies Insight therapies Relationship therapies Relationship therapies Behavior therapies Behavior therapies Cognitive therapies

Documents
Novel Therapies for Triple Negative, HER2+ and ER+ …...Novel Therapies for Triple Negative, HER2+ and ER+ Breast Cancer Joyce O’Shaughnessy, MD Celebrating Women Chair in Breast

Novel Therapies for Triple Negative, HER2+ and ER+ …...Novel Therapies for Triple Negative, HER2+ and ER+ Breast Cancer Joyce O’Shaughnessy, MD Celebrating Women Chair in Breast

Documents
HER2-positive gastric cancer - Springer · 2017-08-27 · ‘‘HER2-positive gastric cancer,’’ similar to HER2-positive breast cancer. It is expected that more anti-HER2 drugs

HER2-positive gastric cancer - Springer · 2017-08-27 · ‘‘HER2-positive gastric cancer,’’ similar to HER2-positive breast cancer. It is expected that more anti-HER2 drugs

Documents
Inhibition of abnormal HER2-driven signaling by two HER2 ...€¦ · • These results suggest a new sub-group of breast cancer patients, HER2- with abnormal HER2 signaling (HER2-/HER2

Inhibition of abnormal HER2-driven signaling by two HER2 ...€¦ · • These results suggest a new sub-group of breast cancer patients, HER2- with abnormal HER2 signaling (HER2-/HER2

Documents
Optimizing Anti-HER2 Therapies for HER2 Positive Breast ...gbcc.kr/upload/GBCC Anti-HER2 Therapy Takano 20190426.pdfResults will be reported at SABCS 2019 Nivolumab Evaluation With

Optimizing Anti-HER2 Therapies for HER2 Positive Breast ...gbcc.kr/upload/GBCC Anti-HER2 Therapy Takano 20190426.pdfResults will be reported at SABCS 2019 Nivolumab Evaluation With

Documents
HER2-POSITIVE BREAST CANCER – GLOBAL DRUG FORECAST … · HER2-Positive Breast Cancer – Global Drug Forecast and Market ... 2013 Epidemiology Breast cancer incident ... HER2-Positive

HER2-POSITIVE BREAST CANCER – GLOBAL DRUG FORECAST … · HER2-Positive Breast Cancer – Global Drug Forecast and Market ... 2013 Epidemiology Breast cancer incident ... HER2-Positive

Documents
MICROBIOME-DIRECTED THERAPIES: PAST, PRESENT, AND …

MICROBIOME-DIRECTED THERAPIES: PAST, PRESENT, AND …

Documents
Therapeutic targeting of HER2 CB2R heteromers in HER2 ... · previously reported the presence of these complexes in HER2+ breast cancer tumors (12), but their role in HER2 function

Therapeutic targeting of HER2 CB2R heteromers in HER2 ... · previously reported the presence of these complexes in HER2+ breast cancer tumors (12), but their role in HER2 function

Documents
Repurposing Therapies for Treatment of HER2 Amplified Pancreatic Cancer - Cowley Mark

Repurposing Therapies for Treatment of HER2 Amplified Pancreatic Cancer - Cowley Mark

Health & Medicine
Treating HER2-mutant advanced biliary tract cancer with ... 4, 2019... · Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy

Treating HER2-mutant advanced biliary tract cancer with ... 4, 2019... · Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy

Documents
Treatment of Advanced HR+/HER2- Breast Cancer · 2018-11-29 · therapies in the treatment of HR+/HER2- advanced breast cancer patients • Integrate clinical data regarding the use

Treatment of Advanced HR+/HER2- Breast Cancer · 2018-11-29 · therapies in the treatment of HR+/HER2- advanced breast cancer patients • Integrate clinical data regarding the use

Documents
HER2/neu-directed therapy for biliary tract cancer · 2017-08-29 · RESEARCH ARTICLE Open Access HER2/neu-directed therapy for biliary tract cancer Milind Javle1*, Chaitanya Churi1,

HER2/neu-directed therapy for biliary tract cancer · 2017-08-29 · RESEARCH ARTICLE Open Access HER2/neu-directed therapy for biliary tract cancer Milind Javle1*, Chaitanya Churi1,

Documents
HER2-directed antibodies, affibodies and nanobodies as drug … · 2020. 11. 12. · REVIEW ARTICLE HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in

HER2-directed antibodies, affibodies and nanobodies as drug … · 2020. 11. 12. · REVIEW ARTICLE HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in

Documents
Biomarkers for HER2-directed Therapies : Past Failures and ...gbcc.kr/upload/Ian Krop.pdf · Adapted from Gluck, Clin Breast Cancer 2016. HER2 as a biomarker? CALGB 9840: (paclitaxel

Biomarkers for HER2-directed Therapies : Past Failures and ...gbcc.kr/upload/Ian Krop.pdf · Adapted from Gluck, Clin Breast Cancer 2016. HER2 as a biomarker? CALGB 9840: (paclitaxel

Documents
HER2 Testing in Breast Cancer: 2013 ASCO/CAP HER2 Guideline Update

HER2 Testing in Breast Cancer: 2013 ASCO/CAP HER2 Guideline Update

Documents
Guidelines Pemeriksaan HER2

Guidelines Pemeriksaan HER2

Documents
Treating HER2-mutant advanced biliary tract cancer … 3, 2019 – ESMO GI...Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2 -directed targeted

Treating HER2-mutant advanced biliary tract cancer … 3, 2019 – ESMO GI...Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2 -directed targeted

Documents
Her2 seleccion

Her2 seleccion

Documents
Emerging RAS-directed therapies for cancer

Emerging RAS-directed therapies for cancer

Documents